KMR annually awaited 2022 R&D General Metrics Study readout on productivity, success rates, cycle times and value for discovery and development.
KMR annually awaited 2022 R&D General Metrics Study readout on productivity, success rates, cycle times and value for discovery and development.
Clinical Advantage combines high level strategy with actionable metrics to improve clinical performance. Through studies and applications, clinical advantage offers companies the means to address cycle time, trial cost, productivity, outsourcing and white space.